Factor H binds to platelet integrin αIIbβ3

Platelets

Volumn 19, Issue 7, 2008, Pages 512-519

  Mnjoyan, Zakar ^a   Li, Jun ^a   Afshar Kharghan, Vahid ^a  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

Factor H; Integrin IIb 3; Platelet

Indexed keywords

COMPLEMENT FACTOR H; FIBRINOGEN RECEPTOR;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; BINDING AFFINITY; BINDING SITE; NONHUMAN; PRIORITY JOURNAL; PROTEIN BINDING; RECEPTOR BINDING; THROMBOCYTE ACTIVATION;

ANIMALS; BINDING SITES; BLOOD PLATELETS; CHO CELLS; COMPLEMENT FACTOR H; CRICETINAE; CRICETULUS; HUMANS; PLATELET ACTIVATION; PLATELET GLYCOPROTEIN GPIIB-IIIA COMPLEX; PROTEIN BINDING; TRANSFECTION;

EID: 55349092344     PISSN: 09537104     EISSN: 13691635     Source Type: Journal    
DOI: 10.1080/09537100802238494     Document Type: Article

References (21)

1. Warwicker P, Goodship TH, Donne RL, Pirson Y, Nicholls A, Ward RM. et al. Genetic studies into inherited and sporadic hemolytic uremic syndrome. Kidney Int 1998;53:836-844.
2. Zipfel PF, Hellwage J, Friese MA, Hegasy G, Jokiranta ST, Meri S. Factor H and disease: A complement regulator affects vital body functions. Mol Immunol 1999;36:241-248.
3. Atkinson JP, Goodship TH. Complement factor H and the hemolytic uremic syndrome. J Exp Med 2007;204:1245-1248.
4. Meri S, Pangburn MK. Regulation of alternative pathway complement activation by glycosaminoglycans: Specificity of the polyanion binding site on factor H. Biochem Biophys Res Commun 1994;198:52-59.
5. 2 (CD11b/CD18). J Immunol 1998;160:4057-4066.
6. Jain A, Karadag A, Fohr B, Fisher LW, Fedarko NS. Three SIBLINGs (small integrin-binding ligand, N-linked glycoproteins) enhance factor H's cofactor activity enabling MCP-like cellular evasion of complement-mediated attack. J Biol Chem 2002;277:13700-13708.
7. Vaziri-Sani F, Hellwage J, Zipfel PF, Sjoholm AG, Iancu R, Karpman D. Factor H binds to washed human platelets. J Thromb Haemost 2005;3:154-162.
8. Del Conde I, Cruz MA, Zhang H, Lopez JA, Afshar-Kharghan V. Platelet activation leads to activation and propagation of the complement system. J Exp Med 2005;201:871-879.
9. 3) integrin complexes. Blood 2002;100:2094-2101.
10. Sajid M, Vijayan KV, Souza S, Bray PF. PlA polymorphism of integrin β3 differentially modulates cellular migration on extracellular matrix proteins. Arterioscler Thromb Vasc Biol 2002;22:1984-1989.
11. Fredrickson BJ, Dong JF, McIntire LV, Lopez JA. Shear-dependent rolling on von Willebrand factor of mammalian cells expressing the platelet glycoprotein Ib-IX-V complex. Blood 1998;92:3684-3693.
12. Peerschke EI, Coller BS. A murine monoclonal antibody that blocks fibrinogen binding to normal platelets also inhibits fibrinogen interactions with chymotrypsin-treated platelets. Blood 1984;64:59-63.
13. Xiao T, Takagi J, Coller BS, Wang JH, Springer TA. Structural basis for allostery in integrins and binding to fibrinogen-mimetic therapeutics. Nature 2004;432:59-67.
14. Zipfel PF. Complement factor H: Physiology and pathophysiology. Semin Thromb Hemost 2001;27:191-199.
15. Pangburn MK. Host recognition and target differentiation by factor H, a regulator of the alternative pathway of complement. Immunopharmacology 2000;49:149-157.
16. Peerschke EI, Yin W, Grigg SE, Ghebrehiwet B. Blood platelets activate the classical pathway of human complement. J Thromb Haemost 2006;4:2035-2042.
17. Lawler J, Hynes RO. The structure of human thrombospondin, an adhesive glycoprotein with multiple calcium-binding sites and homologies with several different proteins. J Cell Biol 1986;103:1635-1648.
18. Huber W, Hurst J, Schlatter D, Barner R, Hubscher J, Kouns WC. et al. Determination of kinetic constants for the interaction between the platelet glycoprotein IIb-IIIa and fibrinogen by means of surface plasmon resonance. Eur J Biochem 1995;227:647-656.
19. 3 (GPIIb-IIIa) requires a functional actin cytoskeleton. Arterioscler Thromb Vasc Biol 1995;15:1466-1473.
20. Kirchhofer D, Gailit J, Ruoslahti E, Grzesiak J, Pierschbacher MD. Cation-dependent changes in the binding specificity of the platelet receptor GPIIb/IIIa. J Biol Chem 1990;265:18525-18530.
21. Fedarko NS, Jain A, Karadag A, Fisher LW. Three small integrin binding ligand N-linked glycoproteins (SIBLINGs) bind and activate specific matrix metalloproteinases. FASEB J 2004;18:734-736.